Bogart Wealth, LLC Amgen Inc Transaction History

Bogart Wealth, LLC

$2.1 Billion
Q3 2024

A detailed history of Bogart Wealth, LLC transactions in Amgen Inc stock. As of the latest transaction made, Bogart Wealth, LLC holds 20,039 shares of AMGN stock, worth $5.28 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

20,039

Previous 20,079 0.2%

Holding current value

$5.28 Million

Previous $6.27 Million 2.92%

% of portfolio

0.31%

Previous 0.32%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$309.38 - $337.38 $12,375 - $13,495	-40 Reduced 0.2%	20,039 $6.46 Million
Q2 2024 Jul 31, 2024	SELL	$262.75 - $319.31 $213,615 - $259,599	-813 Reduced 3.89%	20,079 $6.27 Million
Q1 2024 Apr 25, 2024	BUY	$268.87 - $324.56 $234,723 - $283,340	873 Added 4.36%	20,892 $5.94 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $19,433 - $21,922	-76 Reduced 0.38%	20,019 $5.77 Million
Q3 2023 Oct 30, 2023	SELL	$218.65 - $271.46 $2.4 Million - $2.98 Million	-10,966 Reduced 35.3%	20,095 $5.4 Million
Q2 2023 Jul 28, 2023	BUY	$214.27 - $253.37 $1.57 Million - $1.86 Million	7,323 Added 30.85%	31,061 $6.9 Million
Q1 2023 Apr 21, 2023	BUY	$225.79 - $275.2 $678,498 - $826,976	3,005 Added 14.49%	23,738 $5.74 Million
Q4 2022 Feb 06, 2023	SELL	$229.03 - $291.01 $187,575 - $238,337	-819 Reduced 3.8%	20,733 $5.45 Million
Q3 2022 Nov 03, 2022	BUY	$224.46 - $253.15 $754,185 - $850,584	3,360 Added 18.47%	21,552 $4.86 Million
Q2 2022 Jul 22, 2022	BUY	$230.71 - $256.74 $638,143 - $710,142	2,766 Added 17.93%	18,192 $4.43 Million
Q1 2022 Apr 22, 2022	BUY	$219.27 - $242.57 $535,457 - $592,355	2,442 Added 18.81%	15,426 $3.73 Million
Q4 2021 Jan 19, 2022	BUY	$198.88 - $227.6 $353,409 - $404,445	1,777 Added 15.86%	12,984 $2.92 Million
Q3 2021 Oct 15, 2021	BUY	$212.27 - $248.7 $605,394 - $709,292	2,852 Added 34.14%	11,207 $2.38 Million
Q2 2021 Aug 06, 2021	SELL	$233.58 - $259.14 $948,801 - $1.05 Million	-4,062 Reduced 32.71%	8,355 $2.04 Million
Q1 2021 Apr 16, 2021	BUY	$221.91 - $258.6 $811,746 - $945,958	3,658 Added 41.76%	12,417 $3.09 Million
Q4 2020 Jan 14, 2021	BUY	$216.38 - $257.67 $304,013 - $362,026	1,405 Added 19.11%	8,759 $2.01 Million
Q3 2020 Oct 06, 2020	BUY	$234.65 - $260.95 $127,414 - $141,695	543 Added 7.97%	7,354 $1.87 Million
Q2 2020 Jul 08, 2020	BUY	$197.81 - $242.74 $139,060 - $170,646	703 Added 11.51%	6,811 $1.61 Million
Q1 2020 Apr 20, 2020	BUY	$182.24 - $241.7 $130,483 - $173,057	716 Added 13.28%	6,108 $1.24 Million
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $23,272 - $29,913	123 Added 2.33%	5,392 $1.3 Million
Q3 2019 Oct 10, 2019	BUY	$174.11 - $208.62 $38,478 - $46,105	221 Added 4.38%	5,269 $1.02 Million
Q2 2019 Jul 11, 2019	BUY	$166.7 - $195.41 $42,841 - $50,220	257 Added 5.36%	5,048 $930,000
Q1 2019 Apr 08, 2019	BUY	$180.87 - $203.88 $77,593 - $87,464	429 Added 9.83%	4,791 $910,000
Q4 2018 Jan 15, 2019	BUY	$178.4 - $208.25 $44,064 - $51,437	247 Added 6.0%	4,362 $849,000
Q3 2018 Oct 16, 2018	BUY	$185.29 - $208.89 $34,834 - $39,271	188 Added 4.79%	4,115 $853,000
Q2 2018 Jul 13, 2018	BUY	$166.05 - $186.51 $25,737 - $28,909	155 Added 4.11%	3,927 $725,000
Q1 2018 Apr 13, 2018	BUY	$169.43 - $198.0 $103,860 - $121,374	613 Added 19.4%	3,772 $649,000
Q4 2017 Jan 11, 2018	SELL	$168.79 - $188.59 $4,894 - $5,469	-29 Reduced 0.91%	3,159 $549,000
Q3 2017 Oct 12, 2017	BUY	$167.29 - $191.0 $1,171 - $1,337	7 Added 0.22%	3,188 $591,000
Q2 2017 Sep 19, 2017	BUY	N/A	385 Added 13.77%	3,181 $548,000
Q1 2017 Sep 19, 2017	BUY	N/A	2,796	2,796 $459,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bogart Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bogart Wealth, LLC with notifications on news.

Account

Bogart Wealth, LLC Amgen Inc Transaction History